Harmony Biosciences Holdings, Inc.HRMYNASDAQ
Loading
EV/EBITDA Over TimeContracting
Percentile Rank29
3Y CAGR-33.5%
5Y CAGR-65.6%
Year-over-Year Change
Enterprise value to EBITDA ratio
3Y CAGR
-33.5%/yr
Annual compound
5Y CAGR
-65.6%/yr
Recent acceleration
Percentile
P29
Within normal range
vs 5Y Ago
0x
Contraction
Streak
5 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 6.42 | -11.1% |
| 2024 | 7.22 | -11.3% |
| 2023 | 8.14 | -62.7% |
| 2022 | 21.85 | -27.2% |
| 2021 | 30.01 | -97.8% |
| 2020 | 1336.56 | +7947.8% |
| 2019 | -17.03 | +65.9% |
| 2018 | -50.01 | - |